Vimarsana
Biggest News Aggregation in the World

Page 12 - Immunic Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunic Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunic Inc Today - Breaking & Trending Today

Immunic CEO says Q2 results "couldn't be better" - Vimarsana News

Immunic CEO says Q2 results "couldn't be better"

Immunic Inc (NASDAQ:IMUX) president and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive following the release of the Munich-based biotechnology...

Immunic, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update - Vimarsana News

Immunic, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update

– Preclinical Data Published in the Journal of Medicinal Chemistry Identifies Vidofludimus Calcium as a Potent Nurr1 Activator, Reinforcing Neuroprotective...

Immunic to Participate in Investor and Scientific Conferences in August - Vimarsana News

Immunic to Participate in Investor and Scientific Conferences in August

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...

10 Best Rated Penny Stocks to Buy According to Analysts - Vimarsana News

10 Best Rated Penny Stocks to Buy According to Analysts

Investing in small companies, penny stocks, micro-cap or even small-cap companies went out of fashion as soon as the financial markets started to take a beating amid interest rate hikes.

Immunic's (IMUX) Outperform Rating Reiterated at Wedbush - Vimarsana News

Immunic's (IMUX) Outperform Rating Reiterated at Wedbush

Wedbush reiterated their outperform rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a report issued on Thursday morning, Benzinga reports. Wedbush currently has a $5.00 price target on the stock. Separately, StockNews.com began coverage on Immunic in a research report on Thursday, May 18th. They issued a sell rating on the stock. One […]